{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:25:39Z","timestamp":1791876339429,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000042","name":"Amgen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40744-024-00655-4","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T15:03:47Z","timestamp":1709737427000},"page":"553-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Patient\u2013Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-5205","authenticated-orcid":false,"given":"Fabio Massimo","family":"Perrotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scriffignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Delle Sedie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"655_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370. https:\/\/doi.org\/10.1056\/NEJMra1505557.","journal-title":"N Engl J Med"},{"issue":"3","key":"655_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5312\/wjo.v5.i3.328","volume":"5","author":"A Scarno","year":"2014","unstructured":"Scarno A, Perrotta FM, Cardini F, et al. Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World J Orthop. 2014;5(3):328\u201335.","journal-title":"World J Orthop."},{"key":"655_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3899\/jrheum.150805","volume":"43","author":"FM Perrotta","year":"2016","unstructured":"Perrotta FM, Marchesoni A, Lubrano E. Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-\u03b1 drugs. J Rheumatol. 2016;43:350\u20135.","journal-title":"J Rheumatol"},{"key":"655_CR4","doi-asserted-by":"crossref","unstructured":"Ramonda R, Lorenzin M, Carriero A, et al; on behalf Spondyloartritis and Psoriatic Arthritis SIR Study Group \u201cAntonio Spadaro\u201d. Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study. RMD Open. 2021;7(1):e001519.","DOI":"10.1136\/rmdopen-2020-001519"},{"key":"655_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40265-016-0557-4","volume":"76","author":"E Lubrano","year":"2016","unstructured":"Lubrano E, Perrotta FM. Beyond TNF inhibitors: new pathways and emerging treatments for psoriatic arthritis. Drugs. 2016;76:663\u2013773.","journal-title":"Drugs"},{"key":"655_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79:700\u201312.","journal-title":"Ann Rheum Dis"},{"key":"655_CR7","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10067-017-3578-9","volume":"36","author":"DE Furst","year":"2017","unstructured":"Furst DE, Tran M, Sullivan E, et al. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36:2045\u201354.","journal-title":"Clin Rheumatol"},{"key":"655_CR8","first-page":"1","volume":"23","author":"H Ratna","year":"2019","unstructured":"Ratna H. The Importance of Effective Communication in Healthcare Practice. Harvard Publ Health Rev. 2019;23:1\u20136.","journal-title":"Harvard Publ Health Rev."},{"issue":"7","key":"655_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1532-5415.1998.tb02725.x","volume":"46","author":"RC Maly","year":"1998","unstructured":"Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient\u2013physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46(7):889\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"655_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pec.2011.07.017","volume":"87","author":"PM ten Klooster","year":"2012","unstructured":"ten Klooster PM, Oostveen JC, Zandbelt LC, Taal E, Drossaert CH, Harmsen EJ, van de Laar MA. Further validation of the 5-item perceived efficacy in patient\u2013physician interactions (PEPPI-5) scale in patients with osteoarthritis. Patient Educ Couns. 2012;87(1):125\u201330. https:\/\/doi.org\/10.1016\/j.pec.2011.07.017.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"655_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pec.2013.05.009","volume":"93","author":"G Elwyn","year":"2013","unstructured":"Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient\u2013reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013;93(1):102\u20137. https:\/\/doi.org\/10.1016\/j.pec.2013.05.009.","journal-title":"Patient Educ Couns"},{"key":"655_CR12","doi-asserted-by":"crossref","unstructured":"Watson L, Coyle C, Whately-Smith C, et al. An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis. Rheumatology (Oxford). 2023:kead621.","DOI":"10.1093\/rheumatology\/kead621"},{"key":"655_CR13","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"655_CR14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3899\/jrheum.151404","volume":"43","author":"E Lubrano","year":"2016","unstructured":"Lubrano E, Parsons WJ, Perrotta FM. Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors. J Rheumatol. 2016;43:918\u201323.","journal-title":"J Rheumatol"},{"key":"655_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59:686\u201391.","journal-title":"Arthritis Rheum"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3899\/jrheum.150595","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Parsons WJ, Marchesoni M. Patient\u2019s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol. 2015;42:2332\u20138.","journal-title":"J Rheumatol"},{"key":"655_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811\u20138.","journal-title":"Ann Rheum Dis"},{"key":"655_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwel PS. Defining disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69:48\u201353.","journal-title":"Ann Rheum Dis"},{"key":"655_CR19","unstructured":"Ranza R, Marchesoni A, Calori G, Bianchi G, Braga M, Canazza S, et al. The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol. 1993;11:123\u20138."},{"issue":"2","key":"655_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/09546634.2020.1800571","volume":"33","author":"Z Yang","year":"2022","unstructured":"Yang Z, Li S, Wang X, Chen G. Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis. J Dermatolog Treat. 2022;33(2):1029\u201336. https:\/\/doi.org\/10.1080\/09546634.2020.1800571.","journal-title":"J Dermatolog Treat"},{"key":"655_CR21","doi-asserted-by":"crossref","unstructured":"Gossec L, de Wit M, Kiltz U, et al. EULAR PsAID Taskforce. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73(6):1012\u20139.","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"655_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13075-018-1626-8","volume":"20","author":"TW Swinnen","year":"2018","unstructured":"Swinnen TW, Westhovens R, Dankaerts W, de Vlam K. Widespread pain in axial spondyloarthritis: clinical importance and gender differences. Arthritis Res Ther. 2018;20:156.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"655_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s40744-021-00367-z","volume":"8","author":"LC Coates","year":"2021","unstructured":"Coates LC, Azevedo VF, Cappelleri JC, et al. Exploring the quality of communication between patients with psoriatic arthritis and physicians: results of a global online survey. Rheumatol Ther. 2021;8(4):1741\u201358. https:\/\/doi.org\/10.1007\/s40744-021-00367-z.","journal-title":"Rheumatol Ther."},{"issue":"12","key":"655_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/1744666X.2020.1685382","volume":"15","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis. Expert Rev Clin Immunol. 2019;15(12):1303\u201312.","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00655-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:30:11Z","timestamp":1716391811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00655-4","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fabio Massimo Perrotta, Silvia Scriffignano, Laura Coates and Ennio Lubrano are Editorial Board members of <i>Rheumatology and Therapy<\/i>. Fabio Massimo Perrotta, Silvia Scriffignano, Laura Coates and Ennio Lubrano were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Rossana Scrivo, Salvatore D\u2019Angelo and Andrea Delle Sedie have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study was approved by the Institutional Review Board of the University of Molise (Prot. n. 17\/2021), which covered all four tertiary rheumatological centers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}